ASCIA News
-
Further important information about EpiPen® Jr Supply
5 December 2019: ASCIA has been notified that EpiPen® Jr will not be available from 5 December 2019. See notice from Mylan Australia here. People who are newly diagnosed or who have used their last EpiPen® Jr may not be able to purchase an EpiPen® Jr device until stock arriv... -
Important notice about EpiPen® Jr Supply
20 November 2019: Supply of EpiPen® Jr 150mcg adrenaline (epinephrine) autoinjectors has been affected due to manufacturing delays from the manufacturer in the US, Meridian Medical Technologies, a Pfizer company. This means that there is currently a shortage of EpiPen® Jr as... -
Parliamentary Inquiry into Allergies and Anaphylaxis
19 November 2019: There were two hearings this week for the Parliamentary Inquiry into Allergies and Anaphylaxis, in Melbourne on Monday 18th November 2019 (10am-5pm) and in Sydney on Tuesday 19th November 2019 (9.30-4.30pm). Hansard records of the hearings will soon be on t... -
ASCIA 2019 Conference Report
12 September 2019: The 30th ASCIA Annual Conference was a great success, with more than 600 registrations and an acclaimed program. Congratulations and thank you to Prof Michaela Lucas and the organising committee (Dr Chris Bundell, Rachael Dunn, A/Prof Mina John, A/Prof Ric... -
ASCIA 2019 Conference Update
30 August 2019: ASCIA 2019 CONFERENCE APP To improve your meeting experience, ASCIA has partnered with myINTERACT, to provide delegates with an ASCIA 2019 Conference App. Downloading the App before the conference is recommended, to ensure convenient access to all the informa... -
Updated ASCIA Guidelines for the acute management of anaphylaxis
30 August 2019: ASCIA Guidelines for the acute management of anaphylaxis have been updated, and the main changes are as follows: Adrenaline dosage in infants, and addition of infant positioning image and wording. Adrenaline dosage in pregnant women. Under signs of anaphylaxi... -
ASCIA 2019 Conference Week: Sponsored dinner meetings
23 August 2019: In addition to the outstanding ASCIA 2019 Conference scientific program, the ASCIA 2019 Gala Dinner and the ASCIA Welcome/Closing Functions, the following sponsored dinner meetings are being held on Tuesday, Wednesday and Friday nights during the ASCIA 2019 C... -
ASCIA 2019 Conference deadlines have been extended to 22 July
In response to several requests, the ASCIA 2019 earlybird registration and abstract submission deadline has been extended by one more week, to midnight on Monday 22nd July. Please note that no further extensions will be possible. To register at the discounted earlybird rate...
About ASCIA
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases
Quick Links
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Accreditiation
This site complies with the HONcode standard for trustworthy health information: verify here.